Stocks · Korea
041960
KOSDAQ
Komipharm International
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+12.70%
1M+17.27%
3M+39.24%
6M+29.26%
1Y+65.66%
YTD+46.08%
52W high11,420원
52W low5,650원
From 52W high-3.68%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 398억 | -38억 | -75억 | -9.6% |
| 2023 | 426억 | -63억 | -59억 | -14.7% |
| 2024 | 588억 | 62억 | 147억 | 10.5% |
| 2025 | 525억 | 20억 | -80억 | 3.7% |
| Quarterly | ||||
| 2024 4Q | 157억 | 4억 | 2억 | 2.4% |
| 2025 1Q | 144억 | 5억 | -1억 | 3.5% |
| 2025 2Q | 137억 | 16억 | -33억 | 11.9% |
| 2025 3Q | 125억 | 65,724,728원 | -3억 | 0.5% |
| 2025 4Q | 119억 | -2억 | -43억 | -2.0% |
| 2026 1Q | 119억 | 3억 | 7억 | 2.5% |
Company
Address: 경기도 시흥시 경제로 17
Peers in the same sector
Recent filings
- 2026-08-13반기보고서 (2026.06)
- 2026-05-14분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.